These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19519344)
41. Doramectin concentration profiles in the gastrointestinal tract of topically-treated calves: Influence of animal licking restriction. Sallovitz JM; Lifschitz A; Imperiale F; Virkel G; Larghi J; Lanusse C Vet Parasitol; 2005 Oct; 133(1):61-70. PubMed ID: 15994007 [TBL] [Abstract][Full Text] [Related]
42. Need for a sustainable use of medicinal products: environmental impacts of ivermectin. Mancini L; Lacchetti I; Chiudioni F; Cristiano W; Di Domenico K; Marcheggiani S; Carere M; Bindi L; Borrello S Ann Ist Super Sanita; 2020; 56(4):492-496. PubMed ID: 33346176 [TBL] [Abstract][Full Text] [Related]
43. The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination. Gandolf AR; Lifschitz A; Stadler C; Watson B; Galvanek L; Ballent M; Lanusse C J Zoo Wildl Med; 2009 Mar; 40(1):107-12. PubMed ID: 19368248 [TBL] [Abstract][Full Text] [Related]
45. Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy? Löscher W Epilepsia; 2023 Mar; 64(3):553-566. PubMed ID: 36645121 [TBL] [Abstract][Full Text] [Related]
46. Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment. Olsén L; Ingvast-Larsson C; Bondesson U; Broström H; Tjälve H; Larsson P J Vet Pharmacol Ther; 2007 Jun; 30(3):194-200. PubMed ID: 17472650 [TBL] [Abstract][Full Text] [Related]
47. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment. Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667 [TBL] [Abstract][Full Text] [Related]
48. Macrocyclic lactones for parasite control in equids. Lyons ET; Tolliver SC Curr Pharm Biotechnol; 2012 May; 13(6):1070-7. PubMed ID: 22039797 [TBL] [Abstract][Full Text] [Related]
49. Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults. Brussee JM; Schulz JD; Coulibaly JT; Keiser J; Pfister M Clin Pharmacol Ther; 2019 Sep; 106(3):661-667. PubMed ID: 30993667 [TBL] [Abstract][Full Text] [Related]
50. The changing landscape of antiparasitic drug discovery for veterinary medicine. Geary TG; Conder GA; Bishop B Trends Parasitol; 2004 Oct; 20(10):449-55. PubMed ID: 15363437 [TBL] [Abstract][Full Text] [Related]
51. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656 [TBL] [Abstract][Full Text] [Related]
52. P-gp modulating drugs greatly potentiate the in vitro effect of ivermectin against resistant larvae of Haemonchus placei. Heckler RP; Almeida GD; Santos LB; Borges DG; Neves JP; Onizuka MK; Borges FA Vet Parasitol; 2014 Oct; 205(3-4):638-45. PubMed ID: 25178553 [TBL] [Abstract][Full Text] [Related]
53. Ivermectin resistance in a horse in Australia. Edward CL; Hoffmann AA Vet Rec; 2008 Jan; 162(2):56-7. PubMed ID: 18192659 [No Abstract] [Full Text] [Related]
54. Ketoconazole increases the plasma levels of ivermectin in sheep. Alvinerie M; Dupuy J; Kiki-Mvouaka S; Sutra JF; Lespine A Vet Parasitol; 2008 Oct; 157(1-2):117-22. PubMed ID: 18657366 [TBL] [Abstract][Full Text] [Related]
55. Development of the larval migration inhibition test for comparative analysis of ivermectin sensitivity in cyathostomin populations. McArthur CL; Handel IG; Robinson A; Hodgkinson JE; Bronsvoort BM; Burden F; Kaplan RM; Matthews JB Vet Parasitol; 2015 Sep; 212(3-4):292-8. PubMed ID: 26120037 [TBL] [Abstract][Full Text] [Related]
56. Disposition of 3H-selamectin and 3H-ivermectin in the brain of the cat flea Ctenocephalides felis felis using micro-image analysis. Phipps AN; Martin-Short MR; Littlewood L; Blanchflower SE; Gration KA Vet Parasitol; 2005 Jul; 131(1-2):89-94. PubMed ID: 15941623 [TBL] [Abstract][Full Text] [Related]
57. Integrated assessment of ivermectin pharmacokinetics, efficacy against resistant Haemonchus contortus and P-glycoprotein expression in lambs treated at three different dosage levels. Alvarez L; Suarez G; Ceballos L; Moreno L; Canton C; Lifschitz A; Maté L; Ballent M; Virkel G; Lanusse C Vet Parasitol; 2015 May; 210(1-2):53-63. PubMed ID: 25841863 [TBL] [Abstract][Full Text] [Related]
58. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. James CE; Davey MW Int J Parasitol; 2009 Jan; 39(2):213-20. PubMed ID: 18708066 [TBL] [Abstract][Full Text] [Related]
59. Nematode resistance to ivermectin (630 and 700μg/kg) in cattle from the Southeast and South of Brazil. Felippelli G; Lopes WD; Cruz BC; Teixeira WF; Maciel WG; Fávero FC; Buzzulini C; Sakamoto C; Soares VE; Gomes LV; de Oliveira GP; da Costa AJ Parasitol Int; 2014 Dec; 63(6):835-40. PubMed ID: 25130588 [TBL] [Abstract][Full Text] [Related]
60. Ivermectin, 'wonder drug' from Japan: the human use perspective. Crump A; Ōmura S Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(2):13-28. PubMed ID: 21321478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]